These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27560041)
1. No Conflict, No Interest. Nipp RD; Moy B JAMA Oncol; 2016 Dec; 2(12):1631-1632. PubMed ID: 27560041 [No Abstract] [Full Text] [Related]
2. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors. Carlson RW; McClure JS JAMA Oncol; 2016 Dec; 2(12):1660. PubMed ID: 27787555 [No Abstract] [Full Text] [Related]
3. Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines. Liu X; Tang LL; Mao YP; Liu Q; Sun Y; Chen L; Lin JC; Ma J Oncologist; 2019 Apr; 24(4):498-504. PubMed ID: 30459237 [TBL] [Abstract][Full Text] [Related]
4. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors. Mitchell AP; Basch EM; Dusetzina SB JAMA Oncol; 2016 Dec; 2(12):1628-1631. PubMed ID: 27561170 [TBL] [Abstract][Full Text] [Related]
5. Study examines drug industry payments to physicians who establish cancer guidelines. Printz C Cancer; 2017 Mar; 123(5):723. PubMed ID: 28221686 [No Abstract] [Full Text] [Related]
6. Guidance for guidelines. Steinbrook R N Engl J Med; 2007 Jan; 356(4):331-3. PubMed ID: 17251529 [No Abstract] [Full Text] [Related]
7. [Conflict of interest in clinical research--trends in guidelines for research ethics in Japan and other countries]. Tashiro M Seishin Shinkeigaku Zasshi; 2010; 112(11):1130-5. PubMed ID: 21351693 [No Abstract] [Full Text] [Related]
8. Internal Medicine Physicians' Financial Relationships with Industry: An Updated National Estimate. Kesselheim AS; Woloshin S; Lu Z; Tessema FA; Ross KM; Schwartz LM J Gen Intern Med; 2019 Feb; 34(2):195-197. PubMed ID: 30291605 [No Abstract] [Full Text] [Related]
9. Unease on industry's role in hypertension debate. Saul S N Y Times Web; 2006 May; ():A1, C9. PubMed ID: 16752458 [No Abstract] [Full Text] [Related]
10. CMA guidelines on MD-drug industry relations part of international trend. Williams JR CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902 [No Abstract] [Full Text] [Related]
11. Industry support and professional medical associations. Jackson RH JAMA; 2009 Aug; 302(7):738; author reply 739. PubMed ID: 19690304 [No Abstract] [Full Text] [Related]
13. Why the data diverge on the dangers of Vioxx: even in medical journals, statistics can be subject to broad interpretation. Pollack A; Abelson R N Y Times Web; 2006 May; ():C1, C5. PubMed ID: 16752456 [No Abstract] [Full Text] [Related]
14. When doctors go to class, industry often foots the bill: lectures tend to feature pills made by course sponsors; companies deny influence; a purple heartburn brochure. Hensley S Wall St J (East Ed); 2002 Dec; ():A1, A12. PubMed ID: 12653117 [No Abstract] [Full Text] [Related]
16. Industry support and professional medical associations. Smith CD; Buyske J; Talamini MA JAMA; 2009 Aug; 302(7):738-9; author reply 739. PubMed ID: 19690303 [No Abstract] [Full Text] [Related]
17. Just how tainted has medicine become? Lancet; 2002 Apr; 359(9313):1167. PubMed ID: 11955529 [No Abstract] [Full Text] [Related]
18. Mixing Dinner and Drugs-Is It Ethically Contraindicated? Essi DF AMA J Ethics; 2015 Aug; 17(8):787-95. PubMed ID: 26270881 [No Abstract] [Full Text] [Related]
19. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts. Brand R State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159 [No Abstract] [Full Text] [Related]
20. These two make quite a team. Kassirer JP Washington Post; 2004 Oct; ():B1, B5. PubMed ID: 15700368 [No Abstract] [Full Text] [Related] [Next] [New Search]